News Center

Home page

Peak Report

News reports

Board approves three investment plans Spike Pharmaceuticals expands again

Release time:

2020-08-14

News from our newspaper 8# April 3 , the group company held the fifth meeting of the 10th board of directors, deliberated and passed three proposals on the capital increase of Shanghai Beika by Jianfeng Pharmaceutical, the acquisition of Anhui Zhongwang Pharmaceutical Company by subsidiary Shanghai Beika, and the annual production of 20 .8 billion solid preparations in Jinxi Production Base of Jianfeng Pharmaceutical.

The three investment plans approved by the board of directors this time are important measures to further strengthen the company's pharmaceutical business segment in accordance with the company's strategic policy of "cooperating and innovating to strengthen the main business, standardizing science and seeking development. Among them, Jianfeng Pharmaceutical Co., Ltd. invested ,000 yuan to increase the capital of Shanghai North Card. After the capital increase is completed, Jianfeng Pharmaceutical Co., Ltd. will account for 61.48% of Shanghai North Card. Shanghai North Card will invest 2062 yuan to acquire Anhui Zhongwang 100% equity.

In 1 this year, Jianfeng Pharmaceutical signed an agreement with relevant parties to invest in Shanghai Beika by way of equity acquisition and capital increase, and completed the investment in 5 . Shanghai Beika and its subsidiary Anhui Xinbeika Company have become the controlling subsidiary of Jianfeng Pharmaceutical. Anhui Zhongwang, which Shanghai Beika acquired this time, is also located in Dongzhi Xiangyu Chemical Industrial Park, Chizhou City, Anhui Province. It is a pharmaceutical intermediate manufacturing enterprise integrating R & D, production and sales, focusing on the R & D, production and sales of characteristic medicines, intermediates, new materials and other fine chemicals. Anhui Zhongwang's main products are oxyfluorocarbons, oxyfluorocarbons, levooxyfluorocarbons, and levooxyfluorocarbons, which have passed on-site audits by well-known domestic pharmaceutical companies. L-fluorocycloester passed an on-site audit of a pharmaceutical company in India. 2017 12 accepted the on-site audit of oxyfluorocarboxylic acid process verification by U.S. pharmaceutical companies, and Zhongwang has been registered as a supplier of oxyfluorocarboxylic acid starting materials in U.S. document DMF . After the completion of the acquisition, the company will make use of Anhui Zhongwang's factory buildings and construction land to plan the construction of pharmaceutical intermediates and API projects, so as to provide a strong guarantee for Jianfeng Pharmaceutical to establish a chemical API base.

At the same time, Jianfeng Pharmaceutical will also invest 50146 yuan to set up a new factory on the north side of the existing factory area of Jianfeng Pharmaceutical in Jinxi District of Jinhua Economic Development Zone to build a preparation manufacturing platform that meets the requirements of GMP in Europe and America. (remaining fruit)

More information

2022 China's Top 100 Building Materials Enterprises 2022 China's Top 100 Cement Clinker Production Capacity Peak even on two authoritative lists

In March, the authoritative organization of the cement industry successively released two series of lists of China's top 500 building materials enterprises in 2022 and China's top 100 cement clinker production capacity in 2022. Jianfeng Group ranked among the "top 100" in the two lists ". The list of China's top 500 building materials enterprises was officially released in early March. This series of lists was selected by the China Building Materials Enterprise Management Association. Through more than 20 years of comprehensive data research on China's building materials industry, referring to international practices, the rankings are based on the company's annual operating income., Cement products, building ceramics, waterproof materials, aluminum-plastic profiles, coatings, glass, building materials equipment manufacturing and other sub-industries related to building materials. Jianfeng Group ranks 96th among the companies on the list and 27th among the cement manufacturers on the list. On March 16, the awarding ceremony of 2022 China's top 100 cement clinker production capacity list was held in Hangzhou. This series of lists is released by China Cement Network, an authoritative organization in China's cement industry. The ranking is based on the total production capacity (excluding the production capacity of other kiln types and grinding stations) of new dry clinker production lines completed and put into operation by Chinese cement enterprises in China as of December 31, 2022. The data statistics are calculated based on the design production capacity and 310 days of annual operation. Jianfeng Group ranked 53rd with an annual design capacity of 3.627 million tons. (this newspaper reporter)

2023

03-21

Company sends off retired employees

On the morning of February 22, the trade union of the group company held a simple and warm farewell party for retired employees in 2021-2022. More than 50 retired employees gathered together to discuss and exchange with Jiang Xiaomeng and other group leaders.

2023

03-04

On the first day of the new year, group leaders went to the grassroots level.

On January 29, the first day of work after the Spring Festival holiday, the leaders of the group company made a video connection to subordinate enterprises stationed abroad, and separately visited the gold enterprises to learn about the resumption of work and put forward requirements for the implementation of the work plan for the new year.

2023

02-17

Group Companies Commend 2022 Advanced

On the morning of January 18, the group company held the 2022 annual summary commendation meeting to review the work of the previous year, make arrangements for the work in 2023, sign the 2023 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2022 advanced collectives and individuals.

2023

01-29

Jiang Xiaomeng re-elected chairman of the Municipal Federation of Industry and Commerce

On December 24, 2022, the Jinhua Federation of Industry and Commerce (General Chamber of Commerce) held the seventh member representative meeting. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, was re-elected as the chairman of the Municipal Federation of Industry and Commerce at this meeting.

2023

01-12

Peak Pharmaceutical Donates Epidemic Prevention Materials

Since the optimization and adjustment of the new crown infection epidemic management policy, there has been an explosive growth of infected people in the country, and the pressure on the supply of related materials has increased sharply. Before and after New Year's Day, the company has twice organized epidemic prevention materials, through the Jinhua City Charity Federation, Jinhua City Economic and Technological Development Zone Charity Federation targeted donations, a total value of more than 200,000 yuan.

2023

01-12

< 1 2 3 4...61 > 跳转到页